Summit Therapeutics  logo
Summit Therapeutics SMMT
$ 18.52 -0.56%

Quarterly report 2024-Q3
added 10-30-2024

report update icon

Summit Therapeutics EV/EBITDA Ratio 2011-2024 | SMMT

Annual EV/EBITDA Ratio Summit Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-1.66 -265 16.7 -51.4 -24.9 -12.5 - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
16.7 -265 -56.4